syriQ® glass syringes

The all-in-one container and injection device for vaccines

SCHOTT Pharma is one of the leading companies developing high quality prefillable glass syringes with needle (PFS). A common FIOLAX® glass base combined with a deep understanding of syringe systems helps smooth the transition from vials to syringes.

The ready-to-use prefilled glass syringes (PFS) syriQ® ensure safety and efficiency by eliminating almost all drug injection preparation steps. Extensive options, including the proven syriQ® Rigid Cap (SRC) closure system, allow syriQ® to be perfectly tailored to individual vaccine requirements.

syriQ® prefilled glass syrines are supported by continuous development programs to meet the needs of emerging drug technology platforms and customer-specific projects – from traditional inactivated vaccines to breakthrough mRNA solutions.

Your complete glass syringe system

  • High quality Type I FIOLAX® Borosilicate Glass container material.
    Formats range from 0.5-3 ml with a variety of closure systems such as staked needle, Luer Cone, and Luer Lock with syriQ® Rigid Cap (SRC) or OVS® *.
  • Available as a complete system with plungers and plunger rods based on your requirements.
  • Packaged in a nest 100.

* OVS® is a registered trademark of Vetter-Pharma International GmbH, Germany

Sterile Format

Available pre-sterilized in a ready-to-use format

syriQ® prefillable glass syringes from SCHOTT Pharma are manufactured using a state-of-the-art, fully automated production process. The camera-controlled inspection delivers products with consistently high levels of functionality and low cosmetic defects for an efficient fill-and-finish process.

Applications

Optimum safety and convenience for patients with syriQ®

syriQ® glass syringes from SCHOTT Pharma deliver safety and convenience to patients and healthcare providers. They are ideal for storing and injecting a broad range of vaccines, including:

  • Inactivated vaccines, such as those used against influenza
  • Live-attenuated vaccines, such as the MMR combined vaccine
  • Subunit, recombinant, polysaccharide, and conjugate vaccines
  • Breakthrough mRNA vaccines

syriQ® prefillable glass syringes can also be used in diluent applications.

Advantages

Stable storage and easy processing

Offering stable storage and enhanced vaccine shelf life, syriQ® glass PFS are made of FIOLAX® Borosilicate Glass and offer a range of benefits.

  • Tight dimensional tolerances

    Tight dimensional tolerances to ensure accurate filling and functionality.

  • Standard nests

    Delivered in standard nests as part of the SCHOTT iQ® platform for easy processing on standard filling lines.

  • Integrity and reliable functionality

    Proven container closure integrity and reliable functionality of standard and emerging drug models down to -50 °C.

  • Comprehensive portfolio

    Comprehensive portfolio, including pre-tested closure and plunger components, to support customization for drug and fill-and-finish requirements.

  • Comprehensive solutions

    Comprehensive solutions of prefillable glass syringe systems for a range of fill media, volume, component, and transport condition needs

  • Controlled particulate levels

    Container closure integrity, functionality, and controlled particulate levels suitable for low-temperature mRNA applications

  • Excellent gliding performance

    Excellent gliding performance and customized silicone profiles to meet individual requirements

  • Established standard

    Proven vaccine closure system syriQ® Rigid Cap (SRC) is an established standard for adapting to different patient populations

© 2025 Copyright - 安捷智能股份有限公司
- made by bouncin